Fact CheckerSign in

NCT06743958Active, not recruiting

Prehabilitation in Childhood Soft Tissue or Bone Sarcomas

Prehabilitative Training in Children and Adolescents With Soft Tissue or Bone Sarcoma of the Lower Extremity - a Feasibility Study

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

This study aims to investigate the feasibility of a prehabilitative training intervention. The intervention includes specific strength and balance exercises during neoadjuvant chemotherapy with children and adolescents diagnosed with soft tissue or bone tumor in the lower extremity. This explorative approach of prehabilitation might help to reduce muscle and bone weakening and associated functional limitations during and after acute therapy. By designing this study like a controlled clinical trials, the investigators will also gather preliminary data on the intervention's potential effects in enhancing/on the pre-operative condition. The goal is to improve post-operative outcome and rehabilitation processes in children and adolescents diagnosed with soft tissue or bone sarcoma of the lower extremity.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
16 (estimated)
First submitted
25 Nov 2024
Start date
20 Feb 2025
Primary completion date
30 Oct 2027
Lead sponsor
Technical University of Munich
NCT number
NCT06743958

What you commit to

  • Study type: Interventional
  • Planned participants: 16
  • From 20 Feb 2025 to the primary completion date, 30 Oct 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment or developmental delay that hinders comprehension of the instructions in the testing situation, thereby preventing standardized diagnostic data collection and intervention

Lab values

  • Medical contraindications for the implementation of the intervention and measurements, in consultation with the treating physicians (e.g., acute risk of bleeding or fractures, pain, infection, nausea, dizziness, lack of orthopedic clearance for weight-bearing in the tumor region, other acute orthopedic limitations unrelated to the underlying condition, etc.)

Other

  • Language barriers that prevent understanding of the instructions for study participation

Who the study is looking for

  • Diagnosis of a bone tumor or soft tissue sarcoma of the lower extremity
  • Diagnosed less than 10 days ago, confirmed through biopsy
  • Age Range of 6 to 18 years
  • Treatment will be conducted at one of the two designated study sites

Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dr. von Haunersches Kinderspital
Coordinator of this site? Confirm its status
MunichGermanyUnknown status
Technical University of Munich, Germany; TUM School of Medicine and Health, Department of Pediatrics. German Center for Child and Adolescent Health (DZKJ), partner site Munich
Coordinator of this site? Confirm its status
MunichGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.